LAWSUITS NEWS & LEGAL INFORMATION
Harvoni Denied Claim Lawyer Interviews
Harvoni Investigation Focuses on Problematic Insurance Industry Practices
June 11, 2015. By Heidi Turner.
Washington, DC Patients who have a life-threatening illness typically pray for a cure to be found. They don’t tend to expect that if a cure is found and approved by the FDA, that they would then have to fight with insurance companies to have their treatment covered. Unfortunately for many patients with hepatitis C, insurance companies are allegedly denying them access to curative treatments like Harvoni, arguing that patients aren’t sick enough. But some question whether the denials are motivated by profit, instead of patient well-being or medical necessity. “There are patients with hepatitis C whose doctors are prescribing Harvoni as a curative treatment, but they are being denied the treatment by insurance companies,” Anna Haac, attorney at Tycko & Zavareei LLP, says.
Read [ Harvoni Investigation Focuses on Problematic Insurance Industry Practices ]